Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Vitiligo is a systemic disease with psychological effects, and new treatments focus on personalized care.

Customized dermatological treatments effectively address gaps in standard products, especially for complex cases.

Interest in JAK inhibitors for alopecia areata increased significantly after FDA approval, highlighting the need for patient education.

Premature greying in kids can signal health issues like vitamin deficiencies or thyroid problems, which can be treated.

Bacteroides fragilis and Microbacterium sp. T32 may be linked to autoimmune activity in Hashimoto's thyroiditis and alopecia areata.

Lichen planopilaris may have a genetic link.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Vitiligo and alopecia should be covered by Medicaid and TRICARE as medical, not cosmetic, conditions.

Alopecia areata causes hair loss due to immune issues, and while new treatments show promise, no universally effective solution exists yet.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

A person with thyroid problems had rare, swollen, bald spots on their scalp caused by a condition usually found on the shins.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Early diagnosis and aggressive treatment are essential for managing Vogt-Koyanagi-Harada syndrome effectively.

CD44 variant changes start alopecia areata, but don't maintain it.

A complex X chromosome rearrangement can increase the risk of multiple autoimmune diseases.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

People with Alopecia Areata have lower vitamin D levels.

Stress may trigger hair loss by affecting immune protection in hair follicles.

More research is needed to understand and treat morphea effectively.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.